213 related articles for article (PubMed ID: 20805702)
1. [A case of del(16)(q22) in a patient with acute myeloid leukemia with complex karyotype].
Kim M; Lee JW; Lee JK; Hong YJ; Hong SI; Kang HJ; Cho EH; Chang YH
Korean J Lab Med; 2010 Aug; 30(4):329-33. PubMed ID: 20805702
[TBL] [Abstract][Full Text] [Related]
2. Deletion of CBFB in a patient with acute myelomonocytic leukemia (AML M4Eo) and inversion 16.
Egan N; O'Reilly J; Chipper L; Higgins M; Herrmann R; Cannell P
Cancer Genet Cytogenet; 2004 Oct; 154(1):60-2. PubMed ID: 15381374
[TBL] [Abstract][Full Text] [Related]
3. Fluorescence in situ hybridization identifies cryptic t(16;16)(p13;q22) masked by del(16)(q22) in a case of AML-M4 Eo.
Merchant SH; Haines S; Hall B; Hozier J; Viswanatha DS
J Mol Diagn; 2004 Aug; 6(3):271-4. PubMed ID: 15269306
[TBL] [Abstract][Full Text] [Related]
4. Concurrent acute myeloid leukemia with inv(16)(p13.1q22) and chronic lymphocytic leukemia: molecular evidence of two separate diseases.
Lu CM; Murata-Collins JL; Wang E; Siddiqi I; Lawrence H
Am J Hematol; 2006 Dec; 81(12):963-8. PubMed ID: 16917916
[TBL] [Abstract][Full Text] [Related]
5. Acute myeloid leukemia with inv(16) with CBFB-MYH11, 3'CBFB deletion, variant t(9;22) with BCR-ABL1, and del(7)(q22q32) in a pediatric patient: case report and literature review.
Tirado CA; Valdez F; Klesse L; Karandikar NJ; Uddin N; Arbini A; Fustino N; Collins R; Patel S; Smart RL; Garcia R; Doolittle J; Chen W
Cancer Genet Cytogenet; 2010 Jul; 200(1):54-9. PubMed ID: 20513535
[TBL] [Abstract][Full Text] [Related]
6. [Two cases of acute myeloid leukemia with t(16;21)(p11;q22) and TLS/FUS-ERG fusion transcripts].
Chang WR; Park IJ; Lee HW; Park JS; Kim HC; Kim HJ; Han JH; Cho SR
Korean J Lab Med; 2009 Oct; 29(5):390-5. PubMed ID: 19893346
[TBL] [Abstract][Full Text] [Related]
7. Acute myeloid leukemia with inv(16)(p13.1q22), abnormal eosinophils, and absence of peripheral blood and bone marrow blasts.
Mangaru Z; Shetty S; Visconte V; Liu HD; Rogers HJ
Am J Hematol; 2016 Jun; 91(4):E273-4. PubMed ID: 26719044
[No Abstract] [Full Text] [Related]
8. Therapy-related myelodysplastic syndrome/acute myeloid leukemia with del(7)(q22) in a patient with de novo AML.
Kim YG; Cho SY; Park TS; Oh SH; Yoon HJ
Ann Clin Lab Sci; 2011; 41(1):79-83. PubMed ID: 21325260
[TBL] [Abstract][Full Text] [Related]
9. Chromosome change at 16q22 in nonlymphocytic leukemia: clinical implication on leukemia patients with inv(16) versus del(16).
Ohyashiki K; Ohyashiki JH; Kondo M; Ito H; Toyama K
Leukemia; 1988 Jan; 2(1):35-40. PubMed ID: 3422328
[TBL] [Abstract][Full Text] [Related]
10. Spectral karyotyping and fluorescence in situ hybridization analyses identified a novel three-way translocation involving inversion 16 in therapy-related acute myeloid leukemia M4eo.
Ohsaka A; Otsubo K; Yokota H; Hisa T; Saito H; Kozaki T
Cancer Genet Cytogenet; 2008 Jul; 184(2):113-8. PubMed ID: 18617061
[TBL] [Abstract][Full Text] [Related]
11. Inversion and deletion of 16q22 defined by array CGH, FISH, and RT-PCR in a patient with AML.
Dawson AJ; Bal S; McTavish B; Tomiuk M; Schroedter I; Ahsanuddin AN; Seftel MD; Vallente R; Mai S; Cotter PD; Hovanes K; Gorre M; Gunn SR
Cancer Genet; 2011 Jun; 204(6):344-7. PubMed ID: 21763633
[TBL] [Abstract][Full Text] [Related]
12. AML-associated cytogenetic abnormalities (inv (16), del (16), t(8;21)) in patients with myelodysplastic syndromes.
Estey E; Trujillo JM; Cork A; O'Brien S; Beran M; Kantarjian H; Keating M; Freireich EJ; Stass S
Hematol Pathol; 1992; 6(1):43-8. PubMed ID: 1601822
[TBL] [Abstract][Full Text] [Related]
13. [Fluorescence in situ hybridization studies on a myeloid leukemia patient with ins(8;21)(q22;q22.1q22.3)].
Wu YF; Xue YQ; Bai SX; Zhang J; Yao L; Wang Y; Qiu HY; Shen J; Pan JL; Ma QF
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Apr; 26(2):203-6. PubMed ID: 19350517
[TBL] [Abstract][Full Text] [Related]
14. Deletion of 16q11 is a recurrent cytogenetic aberration in acute myeloblastic leukemia during disease progression.
Yamamoto K; Nagata K; Kida A; Hamaguchi H
Cancer Genet Cytogenet; 2001 Nov; 131(1):65-8. PubMed ID: 11734321
[TBL] [Abstract][Full Text] [Related]
15. Trisomy 22 as the sole abnormality is an important marker for the diagnosis of acute myeloid leukemia with inversion 16.
Xu W; Zhou HF; Fan L; Qian SX; Chen LJ; Qiu HR; Zhang SJ; Li JY
Onkologie; 2008 Sep; 31(8-9):440-4. PubMed ID: 18787351
[TBL] [Abstract][Full Text] [Related]
16. Complex t(8;14;21)(q22;q13;q22), a variant of t(8;21), with t(15;21)(q15;p11) in a patient with acute myelogenous leukemia (M1).
Takahashi T; Maruyama Y; Satoh Y; Yoshimoto M; Tsujisaki M
Cancer Genet Cytogenet; 2004 Dec; 155(2):152-3. PubMed ID: 15571802
[No Abstract] [Full Text] [Related]
17. Molecular and clinical advances in core binding factor primary acute myeloid leukemia: a paradigm for translational research in malignant hematology.
Marcucci G; Caligiuri MA; Bloomfield CD
Cancer Invest; 2000; 18(8):768-80. PubMed ID: 11107447
[TBL] [Abstract][Full Text] [Related]
18. RUNX1-MTG16 fusion gene in acute myeloblastic leukemia with t(16;21)(q24;q22): case report and review of the literature.
De Braekeleer E; Douet-Guilbert N; Le Bris MJ; Morel F; Férec C; De Braekeleer M
Cancer Genet Cytogenet; 2008 Aug; 185(1):47-50. PubMed ID: 18656694
[TBL] [Abstract][Full Text] [Related]
19. [Acute myelomonocytic leukemia with inv (16) (p13 q22) disappeared abnormal karyotype during complete remission].
Tsushima Y; Yukita T; Mikami T; Takami H; Aihara M; Kawamura S; Yoshida Y; Chiba Y
Rinsho Ketsueki; 1989 Dec; 30(12):2178-82. PubMed ID: 2621800
[TBL] [Abstract][Full Text] [Related]
20. Fluorescence in situ hybridization identifies inversion 16 masked by t(10;16)(q24;q22), t(7;16)(q21;q22), and t(2;16)(q37;q22) in three cases of AML-M4Eo.
Reddy KS; Wang S; Montgomery P; Grove W; Robertson LE
Cancer Genet Cytogenet; 2000 Jan; 116(2):148-52. PubMed ID: 10640147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
